https://www.selleckchem.com/pr....oducts/eliglustat.ht
To assess the cost-effectiveness of dual influenza and pneumococcal vaccination for the elderly in Shenzhen, China. A Markov state-transition model with a weekly cycle was developed to compare the outcomes of dual influenza and pneumococcal vaccination for the prevention of influenza and pneumococcal infections compared with no vaccination among 70-74years old people in Shenzhen over 5years. The model allowed seasonal variation of influenza activity. We calculated the incremental cost-effectiveness ratio (ICER) with costs and quality
Me gusta
Comentario
Compartir
